The Uromigos

401 Épisodes

1. Episode 243: ASCO 2023 TALAPRO-2: Phase 3 Study of Talazoparib + Enzalutamide

   Publié: 05/06/2023
2. Episode 242: ASCO 2023 THOR study - erdafitinib vs chemo in bladder cancer

   Publié: 05/06/2023
3. Episode 241: Statistics for clinical trials

   Publié: 01/06/2023
4. Episode 240: Preview of GU Cancer at ASCO 2023

   Publié: 30/05/2023
5. Episode 239: The STAMPEDE trial

   Publié: 22/05/2023
6. Episode 238: Paper of the month: Biomarkers for neoadjuvant PD(L)1 therapy

   Publié: 14/05/2023
7. Episode 237: 2023 AUA Highlights

   Publié: 09/05/2023
8. Episode 236: ODAC for olaparib

   Publié: 02/05/2023
9. Episode 235: Danny Heng and the IMDC classification in renal cancer

   Publié: 24/04/2023
10. Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer

    Publié: 19/04/2023
11. Episode 233: Destaques da 14ª reunião internacional brasileira de câncer urológico

    Publié: 15/04/2023
12. Episode 232: Belzutifan in early and late renal cancer

    Publié: 14/04/2023
13. Episode 231: Ursula Vogl, MD in the Rising Star Series

    Publié: 05/04/2023
14. Episode 230: FGFR Inhibition in NMIBC With Sia Daneshmand

    Publié: 28/03/2023
15. Episode 229: Kala Sridhar, MD on PET in Early Bladder Cancer

    Publié: 20/03/2023
16. Episode 228: Karine Tawagi, MD in the Rising Star Series

    Publié: 15/03/2023
17. Episode 227: 2023 ASCO GU Bladder Highlights and Paper of the Month with Michiel Van der Heijden

    Publié: 06/03/2023
18. Episode 226: 2023 ASCO GU Prostate and RCC Highlights With Dan George

    Publié: 27/02/2023
19. Episode 225: ASCO GU 2023: Brian Shuch, MD discusses the ZIRCON Phase III Study of girentuximab PET/CT imaging in RCC

    Publié: 20/02/2023
20. Episode 224: ASCO GU 2023: discussing miR371 for Germ Cell Tumors with Christian Kollmannsberger

    Publié: 20/02/2023